Malagobadan S found that the overexpression of this novel miRNA, miR-6744-5p promotes insomnia in Luminal A and triple-negative breast cancer cell lines and directly targets the NAT1 enzyme40. This evidence concerns the gene NAT1 and triple-negative breast carcinoma.